Genetics testing company 23andMe has filed for Chapter 11 bankruptcy protection in the U.S. to initiate the sale of its ...

A group of House lawmakers launched a probe Thursday into 23andMe’s handling of customers’ sensitive data following the ...

Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have earned a consensus rating of “Hold” from the fifteen research firms that are currently covering the firm, Marketbeat reports. Three ...

Genetics company 23andMe has filed for bankruptcy and its CEO is stepping down, leaving many users concerned about the future of their data.

Kennedy has prioritized autism as one of the chronic illnesses he's determined to tackle in his aim to "Make America Healthy ...

Wojcicki said she intends to become an outside bidder to acquire the company’s assets after her earlier efforts to take 23andMe private failed.

After adjusting for a slew of factors that can influence dementia risk, like age, sex, and education level, the researchers ...

NEW YORK -- 23andMe has filed for Chapter 11 bankruptcy protection ... 23andMe was founded in 2006, with a promise to revolutionize the future of genetics and health care. The company became known for ...

On Sunday, March 23, 23andMe Holding Co. announced it started voluntarily filing for Chapter 11 Bankruptcy in the U.S. Bankruptcy Court for the Eastern District of Missouri, according to a press ...

As 23andMe prepares to be sold, Science News spoke with two experts about what’s at stake and whether consumers should delete their genetic data.

Me, a standard-bearer for the at-home health movement, announced on March 23 that it has filed for Chapter 11 bankruptcy to facilitate a sale, prompting many of its 15 million customers to wonder: ...